The webcasts will bring together a faculty of global experts who have used GW CBD in the treatment of Dravet syndrome (DS) and Lennox-Gastaut syndrome (LGS).
Selim Benbadis is Professor of Neurology at the University of South Florida and is Director of the University of South Florida/Tampa General Hospital Comprehensive Epilepsy Program. He has authored more than 100 articles and book chapters and serves on several editorial boards.
Ulrich Brandl
Prof. Dr.
Germany
University Hospital Jena
Ulrich Brandl is Director of the Department of Neuropaediatrics, University Hospital Jena, Germany, where he also serves as Chairman of the Ethics Committee.
Richard FM Chin
Prof. Dr.
United Kingdom
Royal Hospital for Sick Children, Edinburgh
Richard Chin is Professor of Paediatric Neurology and Clinical Epidemiology, and the Director of the Muir Maxwell Epilepsy Centre, at The University of Edinburgh, UK. He is an Honorary Consultant Paediatric Neurologist at the Royal Hospital for Sick Children (Edinburgh).
Angela M Kaindl
Prof. Dr.
Germany
Charité – Universitätsmedizin Berlin
Angela Kaindl is Director of the Department of Pediatric Neurology and the Center for Chronically Sick Children at Charité – Universitätsmedizin Berlin. She is also Principal Investigator at the Charité Institute of Cell Biology and Neurobiology.
Andreas Schulze-Bonhage
Prof. Dr.
Germany
Epilepsy Center, University Hospital Freiburg
Andreas Schulze-Bonhage is Medical Director at the Freiburg Epilepsy Center, University of Freiburg, and President of the German Society of Epileptology. He is author of more than 340 peer-reviewed publications, has been active as a Principal Investigator in 40 multicentre clinical trials, and receives research funding from the EU, German Federal Ministry of Education and Research (BMBF), Deutsche Forschungsgemeinschaft, and the National Institutes of Health.
Bernhard Steinhoff
Prof. Dr.
Germany
Kork Epilepsy Centre and University of Freiburg
Bernhard Steinhoff is Professor of Neurology and Clinical Neurophysiology at the University of Freiburg and is Medical Director of the Epilepsy Centre Kork. He is a past president of the German Society of Epileptology and author of numerous peer-reviewed papers and book articles.
Elizabeth Thiele
Prof. Dr.
USA
Massachusetts General Hospital
Elizabeth Thiele is Director of the Pediatric Epilepsy Service at Massachusetts General Hospital, Boston, MA, USA, and is Professor of Neurology at the Harvard Medical School. She organised and established the Herscot Center for Tuberous Sclerosis Complex and a ketogenic diet clinic to treat and manage patients with epilepsy.
Sameer M Zuberi
Prof. Dr.
United Kingdom
Royal Hospital for Children, Glasgow
Sameer Zuberi is Consultant Paediatric Neurologist at the Royal Hospital for Children and Honorary Professor of Paediatric Neurology in the University of Glasgow. He leads the Paediatric Neurosciences Research Group and is clinical lead of the Scottish National Genetic Epilepsy Service. His other roles include President of the European Paediatric Neurology Society, Editor-in-Chief of the European Journal of Paediatric Neurology, past Chair of the International League Against Epilepsy (ILAE) Commission on Classification & Terminology (2013-17) and ILAE Nosology & Definitions Task Force Member.
Nick Jones
PhD
United Kingdom
GW Pharmaceuticals Ltd
Nick Jones is Director of Regulatory Affairs at GW Pharmaceuticals Ltd and has 13 years of cannabinoid experience, including a GW-funded PhD in the field of pharmacology elucidating the non-clinical anticonvulsant potential of CBD for the treatment of epilepsies. Nick transitioned to Global Regulatory Affairs after 8 years in the Preclinical Department at GW directing development programmes and overseeing operations.
Faculty Disclosures
Selim Benbadis
Consultant for Brain Sentinel, Cavion, Ceribell, Eisai, Greenwich, LivaNova, NeuroPace, SK Biopharmaceuticals, Sunovion
Speakers’ bureau for Eisai, Greenwich, LivaNova, Sunovion
National Medical Director for RSC Diagnostic Services (EEG)
Florida Medical Director of Stratus/Alliance (EEG)
Member of Epilepsy Study Consortium
Grant support from Cavion, LivaNova, Greenwich, SK Biopharmaceuticals, Sunovion, Takeda, Xenon
Royalties as an author or editor for eMedicine-Medscape-WebMD, UpToDate
Editorial board for Epilepsy.com (Epilepsy Foundation) controversy section, eMedicine-Medscape-WebMD, Epileptic Disorders, Epilepsy and Behavior, Expert Review of Neurotherapeutics
Ulrich Brandl
Honoraria for presentations, lectures, or advisory boards from Bial, Desitin, Eisai, GW Pharmaceuticals, UCB, Zogenix
Richard FM Chin
Honoraria for presentations, lectures, or advisory boards from GW Pharmaceuticals, Zogenix, Eisei
Local principal investigator in GW Pharmaceuticals and Zogenix sponsored clinical trials
GW Pharmaceuticals has provided Epidyolex® free of charge for patients on a named patient basis
Angela M Kaindl
Speaker honoraria from GW Pharmaceuticals
Andreas Schulze-Bonhage
Research support from Bial, BMBF, DFG, EU, HBP, NIH
Honoraria for lectures or advice from Arvelle, Bial, Eisai, GW Pharmaceuticals, UCB
Advisory boards or consultancy agreements from Arvelle, Bial, B. Braun, Desitin, Eisai, GW Pharmaceuticals, UCB
Elizabeth Thiele
Consultant for GW Pharmaceuticals, Zogenix, Biocodex, Aquestive, West Therapeutics, RegenexBio
Research grants from GW Pharmaceuticals, Zogenix
Sameer M Zuberi
Research funding from Epilepsy Research UK, Glasgow Childrens Hospital Charity, UCB Pharma, Dravet Syndrome UK, Ring Chromosome 20 Research & Support, Tenovus Foundation
Honoraria for advisory boards, educational activities and consultancy for GW Pharmaceuticals, Zogenix Ltd, Biocodex, Encoded Genomics, UCB Pharma, Nutricia
Principal investigator on behalf of his institution for commercial research trials for GW Pharmaceuticals and Zogenix Ltd
Register for our Epidyolex®(cannabidiol) shared experience webcasts
Enter your details below to register. Did you already register? Click here to login.
Personal info *
Webcast info
Legal info
Your consent to receive educational / marketing information and communications.
Applicable laws may require GW Pharmaceuticals to obtain your specific consent in order to contact you by email or other electronic means,
and by non-electronic means, with educational and marketing information and communications about GW Pharmaceuticals and its products,
and meetings run by or on behalf of GW Pharmaceuticals, that we feel may be of interest to you.
Providing your consent to GW Pharmaceuticals to send educational / marketing information and communications is voluntary.
You may withdraw your consent at any time by sending an email to unsubscribe@gwpharm.com. Should you withdraw your consent,
it may prevent GW Pharmaceuticals from sending you further information or communications,
although GW Pharmaceuticals may be required or entitled to continue to process your personal data in order to comply with its legal
and regulatory obligations and to protect its legal rights and interests, but at all times, such processing will be in accordance with the Privacy Notice.
Thanks for registering. Please check your email to verify your account.
If you don't receive this email shortly, please check your spam folder.
The email will contain further instructions.
Thanks for submitting a question
Thank you for submitting your question.
All questions will be collated and directed to the relevant speaker(s) for discussion in the live webcasts.
Cookie notice
We use cookies to collect information about how our website is used and to improve the visitor experience.
You can change your browser’s cookie settings at any time.
Please review our cookie policy for more information on the cookies we use.
Click on ‘Accept and close’ to confirm you have read and understood the policy and to accept all cookies or click ‘Configure Cookies’ to modify your cookie preferences.
These are cookies that are required for the operation of our website. They include, for example, cookies that enable you to log into secure areas of our website.
ActiveInactive
Functionality cookies:
These are used to recognise you when you return to our website. This enables us to personalise our content for you, greet you by name and remember your preferences.
ActiveInactive
Analytical or performance cookies:
These allow us to recognise and count the number of visitors and to see how visitors move around our website when they are using it. This helps us to improve the way our website works, for example, by ensuring that users are finding what they are looking for easily.
ActiveInactive
Targeting cookies:
These cookies record your visit to our website, the pages you have visited and the links you have followed. We will use this information to make our website and the advertising displayed on it more relevant to your interests.
Welcome to the GW Pharmaceuticals Epilepsy Focus microsite!
This microsite is intended for UK healthcare professionals or German healthcare professional prescribers only.
Please confirm that you are a registered UK healthcare professional or German healthcare professional prescriber.
Welcome to GW Pharmaceuticals Epilepsy Focus microsite!
Thank you for visiting our microsite.
Please note that this microsite is only accessible to UK healthcare professionals and German healthcare professional prescribers.
For more information about GW Pharmaceuticals, please visit our corporate website.
You are about to leave this website
Please note this link will redirect you to an external website.
Please confirm if you are happy to continue.
Please note this link will redirect you to an external website.
Thank you for completing this form.
Please note that you are not yet fully registered. You will receive an email to your email address from noreply@epilepsy-focus.co.uk with a confirmation link. In order to complete the registration process and gain full access to our e-learning videos and webcasts, please click the link in your confirmation email.
If you do not receive a confirmation email, please check your spam folder.
Also, please verify that you entered a valid email address in our sign-up form.